The Next Wave of Immune Cell Therapy - Report - MDSpire

The Next Wave of Immune Cell Therapy

From CAR T to eTCR: New immune cell therapies push beyond blood cancers

  • April 1, 2026

  • 18 min

Share

Clinical Report: The Next Wave of Immune Cell Therapy

Overview

{'add': 'Include additional examples of genetic mutations targeted by eTCR therapies.'}

Background

{'add': 'Discuss specific limitations of traditional treatments for solid tumors.'}

Data Highlights

{'remove': 'Placeholder text and replace with qualitative insights.'}

Key Findings

{'rephrase': 'Ensure clarity and direct support from the source.'}

Clinical Implications

{'expand': 'Detail specific patient selection criteria.'}

Conclusion

{'add': 'Mention future research directions.'}

Related Resources & Content

  1. The ASCO Post, 2016 -- Immunotherapy Could Be the Wave of the Future, but Problems and Challenges Cannot Be Ignored
  2. The ASCO Post, 2019 -- The Future of Immunotherapy: Building on Checkpoint Blockade
  3. The ASCO Post, 2017 -- The Immune System: Deciphering Recent Advances
  4. FDA -- FDA grants accelerated approval to lifileucel for unresectable or metastatic melanoma
  5. FDA -- FDA grants accelerated approval to afamitresgene autoleucel for unresectable or metastatic synovial sarcoma
  6. The ASCO Post — Combination Immunotherapy for Lung Cancer: The Wave of the Future
  7. FDA grants accelerated approval to lifileucel for unresectable or metastatic melanoma | FDA
  8. FDA grants accelerated approval to afamitresgene autoleucel for unresectable or metastatic synovial sarcoma | FDA
  9. Emerging advances in CAR-T therapy for solid tumors: latest clinical trial updates from 2025 ASCO annual meeting | Journal of Hematology & Oncology | Full Text
  10. CRISPR-Cas9–Edited Tumor-Infiltrating Lymphocytes in Metastatic Colorectal Cancer - The ASCO Post

Original Source(s)

The Next Wave of Immune Cell Therapy

  • April 1, 2026

Related Content

Virtual Staining and the Next Era of Pathology

How AI enables scalable biomarker analysis that preserves tissue samples, addressing some of the most persistent bottlenecks in clinical care and research

2026 ASCO Bladder Cancer Highlights

The Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute presents a succinct summary of all the bladder cancer clinical updates

  • July 2, 2026

  • 1 min
The importance of robust genomic testing for patients

Misako Nagasaka, MD, PhD shared how precision oncology has fundamentally shifted the landscape through the identification of actionable genomic targets for lung cancer treatment.

  • June 25, 2026

  • 1 min